GenSearch’s Post

#InnocanUpdate 🌱 Thriving at the intersection of Pharmaceuticals and Consumer Wellness, Innocan Pharma is revolutionizing health with our cannabinoid science innovations. 📈 2023 was a banner year with revenues skyrocketing by 534% to $13.7M, thanks to our powerhouse, BI Sky Global. Gross profit soared 568%, and we significantly cut our operating loss by 61%! Plus, we boosted our journey with a $1.5M capital raise. Here's to transforming lives and setting new benchmarks in wellness! 💚 InnoCan Pharma #HealthTech #financialgrowth https://bit.ly/4aChhqH Video Source: Innocan Pharma Canine Experiment June 2022(https://lnkd.in/d67WvNN7)

Elevating Pharma Marketing: Embracing Healthcare Trends In the ever-evolving healthcare landscape, pharma's medical departments are realizing the importance of looking beyond molecules. Focusing on disease and therapy trends is crucial for driving innovation and addressing therapy gaps effectively. At Turacoz Group , we advocate for this strategic shift, offering services that align with this vision. Our commitment is to empower pharma companies to lead in this dynamic environment through our expertise in real-world evidence studies, publication support, and more. Let's collaborate to elevate your pharma marketing strategies. Connect with me to explore how Turacoz can empower your brand in this changing healthcare landscape. #PharmaInnovation #HealthcareTrends #Turacoz #EmpoweringPharma

Watch the 5th panel discussion of Health Tech Summit 2.0, led by Dr. Iffat Zafar Aga (Co-Founder, Sehat Kahani), featuring the industry experts, Javed Ghulam Muhammad, (CEO, Martin Dow), Tahir Ahmed (MD, Searle) and Haroon Qassim (MD, PharmEvo). The topic under consideration was "Pioneering Patient Service: Cutting-Edge Innovations in Pharmaceuticals for an Exceptional Patient Experience." Dive into the future of healthcare with this must-watch video! https://lnkd.in/d4hBXE8A #AIMxHTSGlobalImpact #HealthTechSummit

Are you heading to Asembia's #AXS24 Summit later this month? Archbow's Subject Matter Experts and our colleagues from Valuate Health Consultancy and Entrée Health collaborated to create a checklist to help #marketaccess teams prepare for the conference. If you're attending, be sure to join us for a panel discussion on "Optimizing Market Access and Commercialization for New Biotech Product Launches." Details are on the last page of the PDF below. #pharma #biotech

Bicoll offers unique expertise in plant processing. This can be used for different indications in the discovery of novel chemical entities. Within a few weeks, you can come up with a biologically active compound class binding to your target. The proprietary technology has been successfully proven over the course of 25 years. Learn more about how to enhance and improve your success rate in preclinical development. #biotech #success #pharma #drugdiscovery #biologicallyactive #botechgate #digitalpartnering

Join Our Upcoming Webinar: The Devil is in the Details - Developing Successful EU Pharma & MedTech Forecasts. Douglas Willson and Rajat Parmar will share key insights that showcase the critical differences between creating forecasts in the US and European markets. 📅 Date: October 17, 2024 ⏰ Time: 10 AM EST | 1PM BST | 4PM CEST 🔗 Register today: https://lnkd.in/e3biV-ps Don’t miss this opportunity to enhance your forecasting approach in the EU and stay ahead in the evolving Pharma and MedTech landscape! #Webinar #PharmaForecasting #MedTech #EUHealthcare #LifeSciences #MarketAnalytics #Viscadia

Please join Rajat Parmar and me for a webinar later this week where we will review some of the intricacies of Pharma and Med Tech forecasting in the EU. Rajat leads our recently opened EU office in Lucerne, Switzerland, and will be available post-webinar for more in-depth forecasting discussions. #Viscadia #Forecasting #LifeSciences

We’re pleased to share with you some of the key roundtables taking place at the upcoming Disruptive Technology for Clinical Trials Summit on 8 October 2024 in Boston, MA, USA! From addressing strategies for developing #DigitalBiomarkers, to executing #Decentralized clinical trials, there’s a topic for everyone as we collectively work together to integrate innovative #Technology to accelerate clinical R&D, connectivity, and patient-centric outcomes. Join us in Boston this Fall and ensure you’re part of the conversation: https://lnkd.in/eMg3JacE #AMGWorld #DisruptiveClinicalTrials #ClinicalTrials #Clinical 

We're thrilled to be back in NJ for another engaging Pharma CI US event! If you're attending, make sure to stop by and say hello to Michael Kavouksorian and me. Join us Thursday morning for our presentation on navigating and adjusting to disruptors in various areas of the healthcare delivery value chain. It's going to be insightful! 🤔 Looking forward to seeing you there! #PharmaCI #Pharma #Disruptors #DisruptiveHealthcare #CompetitiveIntelligence #MarketIntelligence #Insights #Strategy #HealthTech #Pipeline #Biosimilars #MarketAccess #AI #ML #Digital #Innovation #Biotech #StrategicInsights #DecisionSupport #Healthcare Pharma CI Conference

In 2023, deal volume declined across the #healthcare and life sciences sectors, but deal value rose because of notable megadeals in pharma and medtech. Learn more in our 2024 Global M&A Report.